Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Pregnancy can cause skin changes and conditions that need correct diagnosis and treatment for the health of the mother and baby.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Selenium supplements can help improve symptoms and metabolic markers in lupus patients.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Polymeric nanoparticles show promise for treating skin diseases.

Skin aging reflects overall body aging and can indicate internal health conditions.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

The document says that there are treatments for hair and nail diseases.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Early diagnosis and a strict gluten-free diet are crucial for children with celiac disease to improve symptoms.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Both mouse and rat models are effective for testing alopecia areata treatments.